Contraception
Volume 79, Issue 6 , Pages 424-427 , June 2009

Association between efficacy and body weight or body mass index for two low-dose oral contraceptives

  • Ronald T. Burkman

      Affiliations

    • Baystate Medical Center, Springfield, MA 01199, USA
    • Corresponding Author InformationCorresponding author. Department of Obstetrics and Gynecology, Baystate Medical Center, 759 Chestnut St., Springfield, MA 01199, USA. Tel.: +1 413 794 5256; fax: +1 413 794 3354.
    • ,
  • Alan C. Fisher

      Affiliations

    • Ortho-McNeil Janssen Scientific Affairs, LLC, Raritan, NJ 08869, USA
    • ,
  • George J. Wan

      Affiliations

    • Ortho-McNeil Janssen Scientific Affairs, LLC, Titusville, NJ 08560, USA
    • ,
  • Christopher E. Barnowski

      Affiliations

    • Johnson & Johnson Regenerative Therapeutics, LLC, Raynham, MA 02767, USA
    • ,
  • Katherine D. LaGuardia

      Affiliations

    • Ortho-McNeil Janssen Scientific Affairs, LLC, Raritan, NJ 08869, USA

Received 26 February 2008 ,Revised 23 December 2008 ,Accepted 23 December 2008.

References 

  1. Holt VL, Scholes D, Wicklund KG, Cushing-Haugen KL, Daling JR. Body mass index, weight, and oral contraceptive failure risk. Obstet Gynecol. 2005;105:46–52
  2. Holt VL, Cushing-Haugen KL, Daling JR. Body weight and risk of oral contraceptive failure. Obstet Gynecol. 2002;99:820–827
  3. Grubb GS, Moore D, Anderson NG. Pre-introductory clinical trials of Norplant implants: a comparison of seventeen countries' experience. Contraception. 1995;52:287–296
  4. Gu S, Sivin I, Du M, et al. Effectiveness of Norplant implants through seven years: a large-scale study in China. Contraception. 1995;52:99–103
  5. Zieman M, Guillebaud J, Weisberg E, Shangold GA, Fisher AC, Creasy GW. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data. Fertil Steril. 2002;77:S13–S18
  6. Brunner Huber LR, Toth JL. Obesity and oral contraceptive failure: findings from the 2002 National Survey of Family Growth. Am J Epidemiol. 2007;166:1306–1311
  7. Brunner LR, Hogue CJ. The role of body weight in oral contraceptive failure: results from the 1995 National Survey of Family Growth. Ann Epidemiol. 2005;15:492–499
  8. Brunner Huber LR, Hogue CJ, Stein AD, Drews C, Zieman M. Body mass index and risk for oral contraceptive failure: a case–cohort study in South Carolina. Ann Epidemiol. 2006;16:637–643
  9. Kaneshiro B, Edelman A, Carlson N, Nichols M, Jensen J. The relationship between body mass index and unintended pregnancy: results from the 2002 National Survey of Family Growth. Contraception. 2008;77:234–238
  10. Vessey M. Oral contraceptive failures and body weight: findings in a large cohort study. J Fam Plann Reprod Health Care. 2001;27:90–91
  11. Hampton RM, Short M, Bieber E, et al. Comparison of a novel norgestimate/ethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 1/20. Contraception. 2001;63:289–295
  12. U.S. Department of Health and Human Services . Healthy People 2010: Understanding and Improving Health. 2nd ed. Washington, DC: U.S. Government Printing Office; 2000;
  13. U.S. Department of Health and Human Services . Healthy People 2000: National Health Promotion and Disease Prevention Objectives. Washington, DC: U.S. Government Printing Office; 1990;
  14. Rosenberg M. Letter to the editor. Contracept Technol Update. 2006;107

☆ This study was funded by Ortho-McNeil Janssen Scientific Affairs, LLC, a division of Ortho-McNeil Pharmaceutical (Raritan, NJ, USA).

PII: S0010-7824(09)00028-6

doi: 10.1016/j.contraception.2008.12.013

Contraception
Volume 79, Issue 6 , Pages 424-427 , June 2009

Article Tools